Mammographic densities and breast cancer risk

Breast Disease

Volumn 10, Issue 3-4, 1998, Pages 113-126

  Boyd, N F ^a,b   Lockwood, G A ^a   Martin, L J ^a   Knight, J A ^b   Byng, J W ^c   Yaffe, M J ^c   Tritchler, D L ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b CANCER CARE ONTARIO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; SEX HORMONE;

ADIPOSE TISSUE; ARTICLE; BREAST CANCER; CANCER RISK; CELL PROLIFERATION; CONNECTIVE TISSUE; DENSITY; DNA DAMAGE; EPITHELIUM; FEMALE; HUMAN; LIPID PEROXIDATION; MAMMOGRAPHY; MITOGENESIS; MUTAGENESIS; PRIORITY JOURNAL;

EID: 0031655356     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/BD-1998-103-412     Document Type: Article

References (102)

1. Ingleby H, Gerson-Cohen J. Comparative anatomy, pathology and roentgenology of the breast. Philadelphia, University of Philadelphia Press; 1960.
2. Shigenaga MK, Ames BN. Oxidants and mitogenesis as causes of mutation and cancer: the influence of diet. Basic Life Sciences 1993; 61:419-436.
3. Wolfe JN. Breast parenchymal patterns and their changes with age. Radiology 1976; 121:545-552.
4. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR 1976; 126:1130-1139.
5. Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 1976; 37:2486-2492.
6. Egan RL, Mosteller RC. Breast cancer mammography patterns. Cancer 1977; 40:2087-2090.
7. Krook PM, Carlile T, Bush W, Hall MH. Mammographic parenchymal patterns as a risk indicator for prevalent and incident cancer. Cancer 1978; 41:1093-1097.
8. Krook PM. Mammographic parenchymal patterns as risk indicators for incident cancer in a screening program: an extended analysis. AJR 1978; 131:1031-1035.
9. Threatt B, Norbeck JM, Ullman NS. Association between mammographic parenchymal pattern classification and incidence of breast cancer. Cancer 1980; 45:2550-2556.
10. Egan RL, McSweeney MB. Mammographic parenchymal patterns and risk of breast cancer. Radiology 1979; 133:65-70.
11. Moskowitz M, Gartside P, McLaughlin C. Mammographic patterns as markers for high-risk benign breast disease and incidence cancers. Radiology 1980; 134:293-295.
12. Tabar L, Dean PB. Mammographic parenchymal patterns. Risk indicator for breast cancer? JAMA 1982; 247:185-189.
13. Witt I, Steen Hansen H, Brunner S. The risk of developing breast cancer in relation to mammography findings. Eur J Radiol 1984; 4:65-67.
14. Gravelle IH, Bulstrode RD, Wang DY. A prospective study of mammographic parenchymal patterns and risk of breast cancer. Br J Radiol 1986; 59:487-491.
15. Thurfjell E, Hsieh CC, Lipworth L, Ekbom A, Adami HO, Trichopouls D. Breast size and mammographic pattern in relation to breast cancer risk. Eur J Cancer Prev 1996; 5:37-41.
16. Ciatto S, Zappa M. A prospective study of the value of mammographic patterns as indicators of breast cancer risk in a screening experience. Eur J Radiol 1993; 17:122-125.
17. Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG. A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Contol 1995; 6:431-438.
18. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: Effects with time, age, and menopause status. J Natl Cancer Inst 1995; 87:1622-1629.
19. De Stavola BL, Gravelle IH, Wang DY, Allen DS, Bulbrook RD, Fentiman IS, et al. Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study. Int J Epidemiol 1990; 19:247-254.
20. Saftlas A, Wolfe J, Hoover R, Brinton L, Schairer C, Salane M, et al. Mammographic parenchymal patterns as indicators of breast cancer risk. Am J Epidemiol 1989; 129:518-526.
21. Boyd NF, Wolfson C, Moskowitz M, Carlile T, Petitclerc C, Ferri HA, et al. Observation variation in the classification of mammographic parenchymal pattern. J Chron Dis 1986; 39:465-472.
22. Toniolo P, Bleich AR, Beinart C, Koenig KL. Reproducibility of Wolfe's classification of mammographic parenchymal patterns. Prev Med 1992; 21:1-7.
23. Boyd NF, O'Sullivan B, Campbell JE, Fishell E, Simor I, Cooke G, et al. Mammographic signs as risk factors for breast cancer. Br J Cancer 1982; 45:185-193.
24. Brisson J, Merletti F, Sadowsky NL. Mammographic features of the breast and breast cancer risk. Am J Epidemiol 1982; 115:428-437.
25. Brisson J, Morrison AS, Kopans DB. Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 1984; 119:371-381.
26. Brisson J, Verreault R, Morrison A, Tennina S, Meyer F. Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 1989; 130:14-24.
27. Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR 1987; 148:1087-1092.
28. Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M, et al. Mammographic densities and risk of breast cancer. Cancer 1991; 67:2833-2838.
29. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995; 87:670-675.
30. Baker LH. Breast Cancer Detection Demonstration Project: five-year summary report. CA Cancer J Clin 1982; 32:194-225.
31. Miller AB, Howe GR, Wall C. Protocol for a Canadian randomized controlled trial of screening for breast cancer in women. Clin Invest Med 1981; 4:233-246.
32. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992; 147:1459-1476.
33. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992; 147:1477-1594.
34. Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst 1992; 84:781-785.
35. Whitehead J, Carlile T, Kopecky KJ, et al. Wolfe mammogrpahic parenchymal patterns: a study of the masking hypothesis of Egan and Mosteller. Cancer 1985; 56:1280-1286.
36. Fisher E, Palekar A, Kim W, Redmond C. The histopathology of mammographic patterns. Am J Clin Pathol 1978; 69:421-426.
37. Bright R, Morrison A, Brisson J, et al. Relationship between mammographic and histologic features of breast tissue in women with benign biopsies. Cancer 1988; 61:266-271.
38. Urbanski S, Jensen HM, Cooke G, et al. The association of histological and radiological indicators of breast cancer risk. Br J Cancer 1988; 58:474-479.
39. Wellings SR, Wolfe J. Correlative studies of the histological and radiographic appearance of the breast parenchyma. Radiology 1978; 129:299-306.
40. Bartow SA, Pathak DR, Mettler FA. Radiographic microcalcification and parenchymal pattern as indicators of histologic "high-risk" benign breast disease. Cancer 1990; 66:1721-1725.
41. Boyd NF, Jensen H, Cooke G, Lee Han HW. Relationship between mammographic and histological risk factors for breast cancer. J Natl Cancer Inst 1992; 84:1170-1179.
42. Bland KI, Kuhns JG, Buchanan JB, et al. A clinicopathologic correlation of mammographic parenchymal patterns and associated risk factors for human mammary carcinoma. Ann Surg 1982; 195:582-594.
43. Cullen KJ, Lippman ME. Stromal-epithelial interactions in breast cancer. In: Dickson RB, Lippman ME, eds. Boston, Kluwer; 1991:413-431.
44. Sakakura T. New aspects of stroma-parenchyma relations in mammary gland differentiation. Int Rev Cytol 1991; 125:165-202.
45. Dickson RB, Lippman ME. Growth factors in breast cancer. Endocr Rev 1995; 16:559-589.
46. Oza AM, Boyd NF. Mammographic parenchymal patterns: A marker of breast cancer risk. Epidemiol Rev 1993; 15:196-208.
47. Grove JS, Goodman MJ, Gilbert F. Factors associated with mammographic pattern. Br J Radiol 1985; 58:21-25.
48. Grove JS, Goodman MJ, Gilbert FI, Clyde D. Factors associated with breast structures in breast cancer patients. Cancer 1979; 43:1895-1899.
49. Brisson J, Sadowski NL, Twaddle JA, Morrison AS, Cole P, Merietti F. The relation of mammographic features of the breast to breast cancer risk factors. Am J Epidemiol 1982; 115:438-443.
50. Bartow SA, Pathak DR, Mettler FA, Key CR, Pike MC. Breast mammographic pattern: a concatentation of confounding and breast cancer risk factors. Am J Epidemiol 1995; 142:813-819.
51. Boyd NF, Greenberg C, Lockwood G, et al. Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: Results from a randomized trial. J Natl Cancer Inst 1997; 89:488-496.
52. Cyrlak D, Wong CH. Mammographic changes in postmenopausal women undergoing hormonal replacement therapy. AJR. 1993; 161:1177-1183.
53. Doyle GJ, McLean L. Unilateral increase in mammographic density with hormone replacement therapy. Clin Radiol 1994; 49:50-51.
54. Kaufman Z, Garstin WI, Hayes R. The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 1991; 43:389-392.
55. Laya MB, Gallagher JC, Schreiman JS. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995; 196:433-437.
56. Berkowitz JE, Gatewood OMB, Goldblum LE, Gayler BW. Hormonal replacement therapy: mammographic manifestations. Radiology 1990; 174:199-201.
57. Stomper PC, VanVoorhis BJ, Ravnikar VA, Meyer JE. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 1990; 174:487-490.
58. Bergkvist L, Tabar L, Adami HO, Persson I, Bergstrom R. Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment. Am J Epidemiol 1989; 130:503-510.
59. Spicer DV, Ursin G, Parisky YR, et al. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 1994; 86:431-436.
60. Ursin G, Pike MC, Spicer DV, Porrath SA, Reitherman RW. Can mamographic densities predict effects of tamoxifen on the breast? J Natl Cancer Inst 1996; 88:128-129.
61. Meyer F, Brown JB, Morrison AS, MacMahon B. Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Natl Cancer Inst 1986; 77:613-616.
62. Kaufman Z, Garstin WIH, Hayes R, Mitchell MJ, Baum M. The mammographic parenchymal patterns of nulliparous women and women with a family history of breast cancer. Clin Radiol 1991; 43:385-388.
63. Whitehead J, Carlile T, Kopecky KJ, et al. The relationship between Wolfe's classification of mammograms, accepted breast cancer risk factors, and the incidence of breast cancer. Am J Epidemiol 1985; 122:994-1006.
64. Bergkvist L, Tabar L, Bergstrom R, Adami HO. Epidemiologic determinants of the mammographic parenchymal pattern. A population-based study within a mammographic screening program. Am J Epidemiol 1987; 126:1075-1081.
65. Hainline S, Myers L, McLelland R. Mammographic patterns and risk of breast cancer. AJR. 1978; 130:1157-1158.
66. Ernster VL, Sacks ST, Peterson CA. Mammographic parenchymal patterns and risk factors for breast cancer. Radiology 1980; 134:617-620.
67. de Waard P, Rombach JJ, Collette HJA, Slotboom B. Breast cancer risk associated with reproductive factors and breast parenchymal patterns. J Natl Cancer Inst 1984; 72:1277-1282.
68. Gram IT, Funkhouser E, Tabar L. Reproductive and menstrual factors in relation to mammographic parenchymal patterns among perimenopausal women. Br J Cancer 1995; 71:647-650.
69. Kelsey JL, Gammon MD, John ES. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15:36-47.
70. Wilkinson E, Clopton C, Gordonson J. Mammographic parenchymal pattern and the risk of breast cancer. J Natl Cancer Ist 1977; 59:1397-1400.
71. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993; 15:110-132.
72. Boyd NF, Martin LJ, Noffel M, Lockwood GA, Tritchler DL. A meta-analysis of studies of dietary fat and breast cancer risk. Br J Cancer 1993; 68:627-636.
73. Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Contol 1994; 5:73-82.
74. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci USA 1995; 92:5258-5265.
75. Vaca CE, Wilhelm J, Harms-Ringdahl M. Interaction of lipid peroxidation products with DNA. A review. Mutat Res 1988; 195:137-149.
76. Esterbauer H. Aldehydic products of lipid peroxidation. In: McBrien DCH, Slater TP, eds. Free Radicals, Lipid Peroxidation and Cancer. London, Academic Press; 1982:101-128.
77. Mukai FH, Goldstein BD. Mutagenicity of malondialdehyde, a decomposition product of peroxidized polyunsaturated fatty acids. Science 1975; 191:868-869.
78. Basu AK, Marnett LJ. Unequivocal demonstration that malondialdehyde is a mutagen. Carcinogenesis 1983; 4:331-333.
79. NIOSH. Carcinogenicity of acetaldehyde and malonaldehyde, and mutagenicity of related low-molecular weight aldehydes. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, Division of Standards Development and Technology Transfer. DDHS (NIOSH) publication no. 91-112. Current intelligence bulletin, 1991.
80. Dhanakoti SN, Draper HH. Response of urinary malondialdehyde to factors that stimulate lipid peroxidation in vivo. Lipids 1987; 22:643-646.
81. Halliwell B, Chirico S. Lipid peroxidation: its mechansim, measurement, and significance. Am J Clin Nutr 1993; 57(suppl):715S-725S.
82. Fang JL, Vaca CE, Valsta LM, Mutanen M. Determination of DNA adducts of malonaldehyde in humans: effects of dietary fatty acid composition. Carcinogenesis 1996; 17:1035-1040.
83. Boyd NF, McGuire V. Evidence of lipid peroxidation in premenopausal women with mammographic dysplasia. Cancer Lett 1990; 50:31-37.
84. Boyd NF, Connelly P, Byng J, et al. Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomarkers Prev 1995; 4:727-733.
85. Musarrat J, Arezina-Wilson J, Wani AA. Porgnostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer 1996; 32A:1209-1214.
86. Malins DC, Holmes EH, Polissar NL, Gunselman SJ. The etiology of breast cancer. Characterisic alterations in hydroxy radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 1993; 71:3036-3043.
87. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: A review of the epdiemiological evidence. Nutr Cancer 1992; 18:1-29.
88. Liehr JG. Dual role of estrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens. Eur J Cancer Prev 1997; 6:3-10.
89. Ames BN, Gold LS. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 1990; 249:970-971.
90. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. "Hormonal" risk factors, "breast tissue age" and the age-incidence of breast cancer. Nature 1983; 303:767-770.
91. Kaizer L, Fishell EK, Hunt JW, Foster S, Boyd NF. Ultrasonographically defined parenchymal patterns of the breast: relationship to mammographic patterns and other risk factors for breast cancer. Br J Radiol 1988; 61:118-124.
92. Blend R, Rideout DF, Kaizer L, Shannon P, Tudor-Roberts B, Boyd NF. Parenchymal patterns of the breast defined by real time ultrasound. Eur J Cancer Prev. 1995; 4:293-298.
93. Poon CS, Bronskill MJ, Henkelman M, Boyd NF. Quantitative magnetic resonance imaging parameters and their relationship to mammographic pattern. J Natl Cancer Inst 1992; 84(10):777-780.
94. Graham SJ, Bronskill MJ, Byng JW, Yaffe MJ, Boyd NF. Quantitative correlation of breast tissue parameters using magnetic resonance and X-ray mammography. Br J Cancer 1996; 73:162-168.
95. Hart BL, Steinbock RT, Mettler Jr FA, Pathak DR, Bartow SA. Age and race related changes in mammographic parenchymal patterns. Cancer 1989; 63:2537-2539.
96. Gravelle IH, Bulbrook RD, Wang DY, et al. A comparison of mammographic parenchymal patterns in premenopausal Japanese and British women. Breast Cancer Res Treat 1991; 18 (Suppl. 1):S93-S95
97. Turnbull AE, Kapera L, Cohen MEL. Mammographic parenchymal patterns in Asian and Caucasian women attending for screening. Clin Radiol 1993; 48:38-40.
98. Yeung KS, Mckeowneyssen GE, Li GF, et al. Comparison of diet and biochemical characteristics of stool and urine between Chinese populations with low and high colorectal cancer rates. J Natl Cancer Inst 1991; 83:46-50.
99. Wolfe JN, Albert S, Belle S, Salane M. Familial influences on breast parenchymal patterns. Cancer 1980; 46:2433-2437.
100. Kaprio J, Alanko A, Kivisaari L. Mammographic patterns in twin pairs discordant for breast cancer. Br J Radiol 1987; 60:459-462.
101. Pankow JS, Vachon CM, Kuni CC, et al. Genetic analysis of mammographic breast density in adult women: Evidence of a gene effect. J Natl Cancer Inst 1997; 89:549-556.
102. Miettenen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 1974; 99:325-332.